Flunixin

Flunixin

Clinical data
AHFS/Drugs.com	International Drug Names
ATCvet code	QM01AG90 (WHO)
Identifiers
IUPAC name 2-[[2-Methyl-3-(trifluoromethyl)phenyl]amino]pyridine-3-carboxylic acid
CAS Number	38677-85-9 Y
PubChem CID	38081
ChemSpider	34911 N
UNII	356IB1O400
KEGG	D04215 Y
ChEBI	CHEBI:76138 N
ChEMBL	ChEMBL1652146 N
CompTox Dashboard (EPA)	DTXSID4048565
ECHA InfoCard	100.115.991
Chemical and physical data
Formula	C14H11F3N2O2
Molar mass	296.249 g·mol−1
3D model (JSmol)	Interactive image
SMILES CC1=C(C=CC=C1NC2=C(C=CC=N2)C(=O)O)C(F)(F)F
InChI InChI=1S/C14H11F3N2O2/c1-8-10(14(15,16)17)5-2-6-11(8)19-12-9(13(20)21)4-3-7-18-12/h2-7H,1H3,(H,18,19)(H,20,21) N Key:NOOCSNJCXJYGPE-UHFFFAOYSA-N N
NY (what is this?)  (verify)

Flunixin is a nonsteroidal anti-inflammatory drug (NSAID), analgesic, and antipyretic used in horses, cattle and pigs. It is often formulated as the meglumine salt. In the United States, it is regulated by the U.S. Food and Drug Administration (FDA), and may only be lawfully distributed by order of a licensed veterinarian. There are many trade names for the product.